Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanlong Ma

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Breast Cancer : Basic and Clinical Research|October 4, 2023
Homologous Recombination Abnormalities Associated With <i>BRCA1/2</i> Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing DataMaher Albitar, Hong Zhang, Andrew Pecora, et al.
Heliyon|May 30, 2023
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumorsMaher Albitar, Hong Zhang, Ahmad Charifa, et al.
Cancer Biomarkers : Section a of Disease Markers|February 27, 2009
Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implicationsWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndromeWanlong Ma, Hagop Kantarjian, Benjamin Bekele, et al.
BMC Medical Genetics|November 17, 2010
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndromeWanlong Ma, Hagop Kantarjian, Ke Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic ModelInhye E Ahn, Xin Tian, David Ipe, et al.
The American Journal of Pathology|October 15, 2022
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial IntelligenceHong Zhang, Muhammad A Qureshi, Mohsin Wahid, et al.
Frontiers in Oncology|July 1, 2022
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid NeoplasmsAndrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, et al.
Blood Advances|April 24, 2020
Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemiaNicholas J Short, Keyur P Patel, Maher Albitar, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Breast Cancer : Basic and Clinical Research|October 4, 2023
Homologous Recombination Abnormalities Associated With <i>BRCA1/2</i> Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing DataMaher Albitar, Hong Zhang, Andrew Pecora, et al.
Heliyon|May 30, 2023
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumorsMaher Albitar, Hong Zhang, Ahmad Charifa, et al.
Cancer Biomarkers : Section a of Disease Markers|February 27, 2009
Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implicationsWanlong Ma, Hagop Kantarjian, Xi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndromeWanlong Ma, Hagop Kantarjian, Benjamin Bekele, et al.
BMC Medical Genetics|November 17, 2010
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndromeWanlong Ma, Hagop Kantarjian, Ke Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2020
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic ModelInhye E Ahn, Xin Tian, David Ipe, et al.
The American Journal of Pathology|October 15, 2022
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial IntelligenceHong Zhang, Muhammad A Qureshi, Mohsin Wahid, et al.
Frontiers in Oncology|July 1, 2022
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid NeoplasmsAndrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, et al.
Blood Advances|April 24, 2020
Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemiaNicholas J Short, Keyur P Patel, Maher Albitar, et al.
Pageof 4